Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ipilimumab (yervoy) (1 trial)
nivolumab (opdivo) (1 trial)
Breast Neoplasms (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)